rs281874753
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_033380.3(COL4A5):c.5038C>T(p.Arg1680*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000912 in 1,096,247 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_033380.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096247Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 361745
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:3
This sequence change creates a premature translational stop signal (p.Arg1674*) in the COL4A5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 12 amino acid(s) of the COL4A5 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Alport syndrome (PMID: 12105244, 20378821, 30577881). This variant is also known as p.Arg1680*. ClinVar contains an entry for this variant (Variation ID: 24785). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the COL4A5 protein in which other variant(s) (p.Arg1677*) have been determined to be pathogenic (PMID: 10094548, 12796257, 19728970, 19965530). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Nonsense variant predicted to result in protein truncation, as the last 12 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12105244, 30577881, 20378821, 30586318) -
X-linked Alport syndrome Pathogenic:2
- -
- -
Alport syndrome Pathogenic:1
In a male patient with Alport syndrome, we found the mutant c.5038C>T (p.Arg1680Ter), which results in a shortened protein that causes illness. His renal pathology showed negative type IV collagen staining for alpha 3 and alpha 5, focal foamy cells in the renal interstitium, and stratified alterations in the basement membrane on electron microscopy, all of which were thought to be signs of renal damage associated with X-linked Alport syndrome. Furthermore, numerous investigations have established the pathogenicity of this mutant location (PMID: 10094548, 12796257, 19728970, 19965530). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at